Work

290 Extending the success of elexacaftor-tezacaftor-ivacaftor to rare mutations—insights from CFTR structure and modulator binding

Year: 2023

Type: article

Source: Journal of Cystic Fibrosis

DOI: 10.1016/s1569-1993(23)01217-1

Authors: B. Kerem, N. Stanleigh, M. Gur, E. Kerem, M. Wilschanski

Institutions: Hebrew University of Jerusalem, Stanford University, Technion – Israel Institute of Technology, Rambam Health Care Campus, Hadassah Medical Center

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Institute of General Medical Sciences

Awards: The ubiquitin proteasome system in ER quality control, G8755052572

OpenAlex ID: W4387746829

FWCI:

Cites: 4

Cited by:

Related to: 10